Advanced Proteome Therapeutics Corporation (APC-H.V)

0.0050 0.0000 (0.00%) At close: 04:55PM EDT

Advanced Proteome Therapeutics Corporation

8337 Eastlake Drive
Suite 104
Burnaby, BC V5A 4W2
Canada
(604) 690-3797
https://www.advancedproteome.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul John Courtney Woodward	President, CEO, Director & Member of Corporate Advisory Board	90k	N/A	1962
Mr. Kenneth Clifford Phillippe B.Comm, CA, CPA	Chief Financial Officer	24.21k	N/A	1952
Mr. Martin John Courtney Woodward	Secretary & Independent Director	N/A	N/A	1968

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.

Corporate governance

Advanced Proteome Therapeutics Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.